Latest News & Updates
Breaking News
3 minutes ago
Vaibhavi M.
Other trending news you may like to read
FDA Grants Breakthrough Status To Biogen’s Litifilimab For Treatment Of Cutaneous Lupus Erythematosus (CLE)
Biogen’s litifilimab receives FDA Breakthrough Therapy Designation for cutaneous lupus, addressing a major unmet need.
Vaibhavi M.
Chugai Seeks Japanese Approval For Tecentriq, Phase III IMvigor011 Data Supports Filing In MRD-Positive Muscle-Invasive Bladder Cancer
Chugai seeks Japan approval to use Tecentriq as adjuvant therapy for MRD-positive muscle-invasive bladder cancer patients.
Vaibhavi M.
Siren Biotechnology Becomes Clinical-Stage Company As FDA Approves IND For Its AAV-Based Cancer Therapy Targeting Recurrent High-Grade Glioma
Siren Biotechnology receives FDA IND clearance to begin first-in-human testing of its AAV immuno-gene therapy for glioma.
Simantini Singh Deo
Seamless Therapeutics Partners With Eli Lilly To Develop Programmable Recombinase Gene Therapies Targeting Genetic Hearing Loss, Potential Deal Over $1.12B
Seamless Therapeutics partners with Eli Lilly to advance programmable recombinase gene therapies targeting genetic hearing loss.
Simantini Singh Deo
